Biogen Pays $124 Million to Develop Gene-Based Therapies

Biogen Pays $124 Million to Develop Gene-Based Therapies

By Carrie Ann - Jul 03, 2015

On Thursday, Biogen Inc. will enter into the area of eye-disease treatment by paying Applied Genetic Technologies Corp. ...

Read More